Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter, randomized, double-blind, placebo-controlled, parallel dose cohort, multiple dose study to evaluate the efficacy, safety, and tolerability of different doses of PB-119 in drug-naïve subjects with T2DM.
Epistemonikos ID: 6f5fa77436427ca0442c487f2b4df0d5813a97b6
First added on: May 21, 2024